Review article · 2026

PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy

Eman M Elkafoury, Tarek Fathy El-Moselhy, Mervat H. El‐Hamamsy, Eman A. El-Bastawissy, Peter A. Sidhom, Hamada S. Abulkhair

Drug Discovery Today, 31(6), 104844 · Published 22 October 2026 · DOI 10.1016/j.drudis.2026.104844

View at the publisherCite this paper

In brief

“PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy” is a 2026 review article by Eman M Elkafoury and 5 co-authors, published in Drug Discovery Today. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
60
Authors
6

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Elkafoury, E. M., El-Moselhy, T. F., El‐Hamamsy, M. H., El-Bastawissy, E. A., Sidhom, P. A., & Abulkhair, H. S. (2026). PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy. Drug Discovery Today, 31(6), 104844. https://doi.org/10.1016/j.drudis.2026.104844

MLA 9

Elkafoury, Eman M, et al. “PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy.” Drug Discovery Today, vol. 31, no. 6, 2026, p. 104844. https://doi.org/10.1016/j.drudis.2026.104844.

Chicago

Elkafoury, Eman M, Tarek Fathy El-Moselhy, Mervat H. El‐Hamamsy, Eman A. El-Bastawissy, Peter A. Sidhom, and Hamada S. Abulkhair. 2026. “PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy.” Drug Discovery Today 31 (6): 104844. https://doi.org/10.1016/j.drudis.2026.104844.

Harvard

Elkafoury, E. M. et al. (2026) ‘PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy’, Drug Discovery Today, 31(6), p. 104844. doi:10.1016/j.drudis.2026.104844.

IEEE

E. M. Elkafoury, T. F. El-Moselhy, M. H. El‐Hamamsy, E. A. El-Bastawissy, P. A. Sidhom, and H. S. Abulkhair, “PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy,” Drug Discovery Today, vol. 31, no. 6, p. 104844, 2026, doi: 10.1016/j.drudis.2026.104844.

BibTeX

@article{elkafoury2026parp,
  title     = {{PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy}},
  author    = {Elkafoury, Eman M and El-Moselhy, Tarek Fathy and El‐Hamamsy, Mervat H. and El-Bastawissy, Eman A. and Sidhom, Peter A. and Abulkhair, Hamada S.},
  journal   = {Drug Discovery Today},
  year      = {2026},
  volume    = {31},
  number    = {6},
  pages     = {104844},
  doi       = {10.1016/j.drudis.2026.104844},
  url       = {https://doi.org/10.1016/j.drudis.2026.104844}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP-1 inhibitors
  • PARP2
  • homologous recombination deficiency
  • poly(ADP-ribosyl)ation
  • PARP trapping
  • hematologic toxicity
  • therapeutic index
  • bone marrow recovery

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Elkafoury, E. M., El-Moselhy, T. F., El‐Hamamsy, M. H., El-Bastawissy, E. A., Sidhom, P. A., & Abulkhair, H. S. (2026). PARP-1 selective inhibitors: A new direction in drug discovery to improve the therapeutic index of PARP-targeted cancer therapy. Drug Discovery Today, 31(6), 104844. https://doi.org/10.1016/j.drudis.2026.104844

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Eman M Elkafoury, Tarek Fathy El-Moselhy, Mervat H. El‐Hamamsy, Eman A. El-Bastawissy, Peter A. Sidhom, Hamada S. Abulkhair.

What is the DOI of this paper?

10.1016/j.drudis.2026.104844, permanently at https://doi.org/10.1016/j.drudis.2026.104844. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.